Recombinant Anti-IL12 x Anti-IL18 Bispecific Antibody (scFv-CH3) contains two chains. The anti-IL12 scFv is fused to the Knob-CH3 domain via a hinge region and the same as the anti-IL18 scFv to the Hole-CH3 domain, or vice versa. The KIH CH3 domains can facilitate to form a heterodimer and this bivalent binding leads to improvement in avidity. This BsAb can bind and inactivate two ligands simultaneously. It is designed for the research of Arthritis therapy.
There are currently no customer reviews or questions for Recombinant Human Anti-IL12 x Human Anti-IL18 Bispecific Antibody (scFv-CH3) (BSFC-H336). Click the button below to contact us or submit your feedback about this product.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRYSERVICES
PRODUCTS
PLATFORMS